1887

Chapter 9 : Models of Immunity

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Models of Immunity, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818203/9781555811556_Chap09-1.gif /docserver/preview/fulltext/10.1128/9781555818203/9781555811556_Chap09-2.gif

Abstract:

This chapter provides a thorough discussion of the naturally occurring immune response to chlamydial infection of the genital tract, respiratory tract, and conjunctiva, including the events leading to resolution of infection, the mechanisms involved in resolution, and the events and mechanisms participating in the immune response to reinfection. The chapter addresses the ongoing development of a chlamydial vaccine including a review of vaccine studies, potential immunogens, and strategies of immunization. Unquestionably, there is a strong immune response in humans resulting from genital, ocular, or respiratory infection with relevant species of . As with many infections, immunity is seldom an all-or-none matter; therefore, a section explores some of the potential parameters which contribute to the resistance or susceptibility to reinfection. In addition, since immunity, particularly in adolescents, appears to be short-lived, any vaccine that is developed must do better than the natural infection, which is something that has proven to be extremely difficult. The chapter further reviews attempts at immunization with different immunogens or forms of immunogens, as well as the effect of the immunization route. Finally, the chapter discusses the potential immunization strategies, based on one's knowledge of the immune response and disease pathogenesis. In evaluating possible vaccine strategies for chlamydial disease, it is important to remember that we are dealing with the prevention of different disease entities. It is unlikely that a single vaccination protocol will be effective against trachoma, genital disease, pneumonia, coronary artery disease, and veterinary diseases.

Citation: Rank R. 1999. Models of Immunity, p 239-295. In Stephens R (ed), Chlamydia. ASM Press, Washington, DC. doi: 10.1128/9781555818203.ch9

Key Concept Ranking

Tumor Necrosis Factor alpha
0.42981496
0.42981496
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555818203.chap9
1. Ahmad, A.,, C. R. Dawson,, C. Yoneda,, B. Togni,, and J. Schachten 1977. Resistance to reinfection with a chlamydial agent (guinea pig inclusion conjunctivitis). Investig. Ophthalmol. Vis. Sci. 16: 549 553.
2. Allen, J. E.,, R. M. Locksley,, and R. S. Stephens. 1991. A single peptide from the major outer membrane protein of Chlamydia trachomatis elicits T cell help for the production of antibodies to protective determinants. J. Immunol. 147: 674 679.
3. Anderson, I. E.,, T. W. Tan,, G. E. Jones,, and A. J. Herring. 1990. Efficacy against ovine enzootic abortion of an experimental vaccine containing purified elementary bodies of Chlamydia psittaci. Vet. Microbiol. 24: 21 27.
4. Arno, J. N.,, B. P. Katz,, R. McBride,, G. A. Carty,, B. E. Batteiger,, V. A. Caine,, and R. B. Jones. 1994. Age and clinical immunity to infections with Chlamydia trachomatis. Sex. Transm. Dis. 21: 47 52.
5. Bailey, R.,, A. Fowler,, R. Peeling,, D. Mabey,, H. Whittle,, and A. Jepson,. 1998. Lymphoproliferative responses to C. trachomatis EBs in a Gambian twin population: estimating the role of host genetic factors, p. 474 477. In R. S. Stephens,, G. I. Byrne,, G. Christiansen,, I. N. Clarke,, J. T. Grayston,, R. G. Rank,, G. L. Ridgway,, R. Saikku,, J. Schachter,, and W. E. Stamm (ed.), Chlamydial Infections. Proceedings of the Ninth International Symposium on Human Chlamydial Infection. International Chlamydia Symposium, San Francisco, Calif..
6. Bailey, R. L.,, M. J. Holland,, H. C. Whittle,, and D. C. W. Mabey. 1995. Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls. Infect. Immun. 63: 389 392.
7. Bailey, R. L.,, M. Kajbaf,, H. C. Whittle,, M. E. Ward,, and D. C. Mabey. 1993. The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective. Epidemiol. Infect. 111: 315 324.
8. Barenfanger, J.,, and A. B. MacDonald. 1974. The role of immunoglobulin in the neutralization of trachoma infectivity. J. Immunol. 113: 1607 1617.
9. Barron, A. L.,, R. G. Rank,, and E. B. Moses. 1984. Immune response in mice infected in the genital tract with mouse pneumonitis agent (Chlamydia trachomatis biovar). Infect. Immun. 44: 82 85.
10. Barron, A. L.,, H. J. White,, R. G. Rank,, B. L. Soloff,, and E. B. Moses. 1981. A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis. J. Infect. Dis. 143: 63 66.
11. Barteneva, N.,, I. Theodor,, E. M. Peterson,, and L. M. de la Maza. 1996. Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection. Infect. Immun. 64: 4830 4833.
12. Batteiger, B. E.,, and R. G. Rank. 1987. Analysis of the humoral immune response in chlamydial genital infection in guinea pigs. Infect. Immun. 55: 1767 1773.
13. Batteiger, B. E.,, R. G. Rank,, P. M. Bavoil,, and L. S. F. Soderberg. 1993. Partial protection against reinfection by immunization of guinea pigs with isolated outer-membrane proteins of the chlamydial agent of guinea pig inclusion conjunctivitis. J. Gen. Microbiol. 139: 2965 2972.
14. Batteiger, B. E.,, R. G. Rank,, and L. S. F. Soderberg,. 1990. Immunization of guinea pigs with isolated chlamydial outer membrane proteins, p. 265 268. In W. R. Bowie,, H. D. Caldwell,, R. P. Jones,, P.-A. Mardh,, G. L. Ridgway,, J. Schachter,, W. E. Stamm,, and M. E. Ward (ed.), Chlamydial Infections. Cambridge University Press, Cambridge, England.
15. Beatty, P. R.,, and R. S. Stephens. 1994. CD8 + T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway. J. Immunol. 153: 4588 4595.
16. Brunham, R.,, C. Yang,, I. Maclean,, J. Rimani,, G. Maitha, and E Plummer. 1994. Chlamydia trachomatis from individuals in a sexually transmitted disease core group exhibit frequent sequence variation in the major outer membrane protein (ompl) gene. J. Clin. Invest. 94: 458 463.
17. Brunham, R. C.,, C.-C. Kuo,, L. Cles,, and K. K. Holmes. 1983. Correlation of host immune responsewith quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect. Immun. 39: 1491 1494.
18. Byrne, G.,, M. Padilla,, D. Lacy,, D. Paulnock,, and X. L. Guo,. 1990. Mouse model for protective immunity to Chlamydia, p. 236 239. In W. R. Bowie,, H. D. Caldwell,, R. B. Jones,, P.-A. Mardh,, G. L. Ridway,, J. Schachter,, W. E. Stamm,, and M. E. Ward (ed.), Chlamydial Infections. Cambridge University Press, Cambridge, England.
19. Byrne, G. L.,, J. M. Carlin,, T. P. Merkert,, and D. L. Arter. 1989. Long-term effects of gamma interferon on chlamydia-infected host cells: microbicidal activity follows microbistasis. Infect. Immun. 57: 1318 1320.
20. Byrne, G. I.,, and C. L. Faubion. 1982. Lymphokine-mediated microbistatic mechanisms restrict Chlamydia psittaci growth in macrophages. J. Immunol. 128: 469 474.
21. Byrne, G. I.,, and D. A. Krueger. 1983. Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin. Infect. Immun. 42: 1152 1158.
22. Byrne, G. I.,, L. K. Lehmann,, and G. J. Landry. 1986. Induction of tryptophan catabolism is the mechanism for gamma interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect. Immun. 53: 347 351.
23. Byrne, G. I.,, and J. W. Moulder. 1978. Parasite-specified phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells. Infect. Immun. 19: 598 606.
24. Byrne, G. I.,, R. S. Stephens,, G. Ada,, H. D. Caldwell,, H. Su,, R. P. Morrison,, B. Van der Pol,, P. Bavoil,, L. Bobo,, S. Everson,, Y. Ho,, R. C. Hsta,, K. Kennedy,, C.-C. Kuo,, P. C. Montgomery,, E. Peterson,, A. Swanson,, C. Whitaker,, J. Whittum-Hudson,, and C. L. Yang. 1993. Workshop on in vitro neutralization of Chlamydia trachomatis: summary of proceedings. J. Infect. Dis. 168: 415 420.
25. Cain, T. K.,, and R. G. Rank. 1995. Local Thl-like responses are induced by intravaginal infection of mice with the mouse pneumonitis (MoPn) biovar of Chlamydia trachomatis. Infect. Immun. 63: 1784 1789.
26. Caldwell, H. D.,, J. Kromhout,, and J. Schachter. 1981. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 31: 1161 1176.
27. Caldwell, H. D.,, and L. J. Perry. 1982. Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein. Infect. Immun. 38: 745 754.
28. Caldwell, H. D.,, S. Stewart,, S. Johnson,, and H. Taylor. 1987. Tear and serum antibody responses to Chlamydia trachomatis antigens during acute chlamydial conjunctivitis in monkeys as determined by immunoblotting. Infect. Immun. 55: 93 98.
29. Campbell, L. A.,, C.-C. Kuo,, S.-P. Wang,, and J. T. Grayston. 1990. Serological response to Chlamydia pneumoniae infection. J. Clin. Microbiol. 28: 1261 1264.
30. Campos, M.,, S. Pal,, T. P. O'Brien,, H. R. Taylor,, R. A. Prendergast,, and J. A. Whittum-Hudson. 1995. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate. Investig. Ophthalmol. Vis. Sci. 36: 1477 1491.
31. Cevenini, R.,, F. Rumpianesi,, V. Sambri,, and M. La Placa. 1986. Antigenic specificity of serological response in Chlamydia trachomatis urethritis detected by immunoblotting. J. Clin. Pathol. 39: 325 327.
32. Chen, W., and C. Kuo. 1980. A mouse model of pneumonitis induced by Chlamydia trachomatis: morphologic, microbiologic, and immunologic studies. Am. J. Pathol. 100: 365 382.
33. Collier, L. H. 1966. The present status of trachoma vaccination studies. Bull. W. H. O. 34: 233 241.
34. Collier, L. H.,, and W. A. Blyth. 1966. Immunogenicity of experimental trachoma vaccines in baboons. I. Experimental methods, and preliminary tests with vaccines prepared in chick embryos and in HeLa cells. J. Hyg. Camb. 64: 513 528.
35. Collier, L. H.,, and W. A. Blyth. 1967. Immunogenicity of experimental trachoma vaccines in baboons. III. Experiments with inactivated vaccines. J. Hyg. Camb. 65: 97 107.
36. Conlan, J. W.,, I. N. Clarke,, and M. E. Ward. 1988. Epitope mapping with solid-phase peptides: identification of type-, subspecies-, species-, and genus-reactive antibody binding domains on the major outer membrane protein of Chlamydia trachomatis. Mol. Microbiol. 2: 673 679.
37. Conlan, J. W.,, S. Ferris,, I. N. Clarke,, and M. E. Ward. 1990. Isolation of recombinant fragments of the major outer-membrane protein of Chlamydia trachomatis: their potential as subunit vaccines. J. Gen. Microbiol. 136: 2013 2020.
38. Conway, D. J.,, M. J. Holland,, R. L. Bailey,, A. E. Campbell,, O. S. M. Mahdi,, R. Jennings,, E. Mbena,, and D. C. W.. Mabey. 1997. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-α) gene promoter and with elevated TNF-α levels in tear fluid. Infect. Immun. 65: 1003 1006.
39. Cotter, T. W.,, Q. Meng,, Z. L. Shen,, Y. X. Zhang,, H. Su,, and H. D. Caldwell. 1995. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect. Immun. 63: 4704 4714.
40. Cotter, T. W.,, Z. H. Ramsey,, G. S. Miranpuri,, C. E. Poulsen,, and G. I. Byrne. 1997. Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect. Immun. 65: 2145 2152.
41. Cui, Z.-D.,, D. Tristram,, L. J. LaScolea,, T. Kwiatkowski, Jr.,, S. Kopti,, and P. L. Ogra. 1991. Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization. Infect. Immun. 59: 1465 1469.
42. Darougar, S.,, M. A. Monnickendam,, H. El-Sheikh,, J. D. Treharne,, R. M. Woodland,, and B. R. Jones,. 1977. Animal models for the study of chlamydial infections of the eye and genital tract, p. 186 198. In D. Hobson, and K. K. Holmes (ed.), Nongonococcal Urethritis and Related Infections. American Society for Microbiology, Washington, D.C..
43. Darville, T.,, C. W. Andrews, Jr.,, K. K. Laffoon,, W. Shymasani,, L. R. Kishen,, and R. G. Rank. 1997. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect. Immun. 65: 3065 3073.
44. Darville, T.,, C. W. Andrews, Jr.,, L. R. Kishen,, R. G. Rank,, and D. M. Williams,. 1998a. Transforming growth factor-/3 is associated with increased pathology in interferon-gamma gene knockout mice infected with chlamydiae, p. 407 410. In R. S. Stephens,, G. I. Byrne,, G. Christiansen,, I. N. Clarke,, J. T. Grayston,, R. G. Rank,, G. L. Ridgway,, P. Saikku,, J. Schachter,, and W. E. Stamm (ed.), Chlamydial Infections. Proceedings of the Ninth International Symposium on Human Chlamydial Infection. International Chlamydia Symposium, San Francisco, Calif..
45. Darville, T.,, K. K. Laffoon,, L. R. Kishen,, and R. G. Rank. 1995. Tumor necrosis factor alpha activity in genital tract secretions of guinea pigs infected with chlamydiae. Infect. Immun. 63: 4675 4681.
46. Darville, T.,, D. M. Williams,, and R. G. Rank. 1998b. Unpublished work.
47. Dascher, C.,, D. Roll,, and P. M. Bavoil. 1993. Expression and translocation of the chlamydial major outer membrane protein in Escherichia coli. Microb. Pathog. 15: 455 467.
48. Dean, D.,, E. Oudens,, G. Bolan,, N. Padian,, and J. Schachter. 1995. Major outer membrane protein variants of Chlamydia trachomatis are associated with severe upper genital tract infections and histopathology in San Francisco. J. Infect. Dis. 172: 1013 1022.
49. Dean, D.,, and R. S. Stephens. 1994. Identification of individual genotypes of Chlamydia trachomatis from experimentally mixed serovars and mixed infections among trachoma patients. J. Clin. Microbiol. 32: 1506 1510.
50. de la Maza, L.,, S. Pal,, A. Khamesipour,, and E. M. Peterson. 1994. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect. Immun. 62: 2094 2097.
51. Dhir, S. P.,, L. P. Agarwal,, R. Detels,, S. P. Wang,, and J. T. Grayston. 1967. Field trial of two bivalent trachoma vaccines in children of Punjab Indian villages. Am. J. Ophthalmol. 63: 1639 1644.
52. Fan, J.,, and R. S. Stephens. 1997. Antigen conformation dependence of Chlamydia trachomatis infectivity neutralization. J. Infect. Dis. 176: 713 721.
53. Fazio, V. M. 1997. "Naked" DNA transfer technology for genetic vaccination against infectious disease. Res. Virol. 148: 101 108.
54. Foggie, A. 1973. Preparation of vaccines against enzootic abortion of ewes. A review of the research work at the Moredun Institute. Vet. Bull. 43: 587 590.
55. Ghaem-Maghami, S.,, R. L. Bailey,, D. C. W. Mabey,, P. E. Hay,, O. S. M. Mahdi,, H. M. Joof,, H. C. Whittle,, M. E. Ward,, and D. J. M. Lewis. 1997. Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachoma. Infect. Immun. 65: 4958 4964.
56. Graham, D. M.,, and J. E. Layton,. 1971. The induction of Chlamydia group antibody in rabbits inoculated with trachoma agents and demonstration of strain-specific neutralizing antibody in sera. In R. L. Nichols (ed.), Trachoma and Related Disorders Caused by Chlamydial Agents. Excerpta Medica, Amsterdam, The Netherlands.
57. Grayston, J. T.,, R. L. Woolridge,, S. Wang,, C. Yen,, C. Yang,, K. Cheng,, and I. Chang. 1963. Field studies of protection from infection by experimental trachoma virus vaccine in preschool-aged children on Taiwan. Proc. Soc. Exp. Biol. Med. 112: 589 595.
58. Grayston, J. T.,, K. S. W. Kim,, E. R. Alexander,, and S.-P. Wang,. 1971. Protective studies in monkeys with trivalent and monovalent trachoma vaccines. In R. L. Nichols (ed.), Trachoma and Related Disorders Caused by Chlamydial Agents. Excerpta Medica, Amsterdam, The Netherlands.
59. Hanna, L.,, E. Jawetz,, O. Briones, H. B. Ostler, H. Keshishyan, and C. R. Dawson. 1973. Antibodies to TRIC agents in matched human tears and sera. J. Immunol. 110: 1464 1469.
60. Hanna, L.,, T. C. Merigan,, and E. Jawetz. 1966. Inhibition of TRIC agents by virus-induced interferon. Proc. Soc. Exp. Biol. Med. 122: 417 421.
61. Harrison, H. R.,, E. R. Alexander,, W. T. Chiang,, W. E. Giddens,, J. T. Boyce,, D. Benjamin,, and J. L. Gale. 1979. Experimental nasopharyngitis and pneumonia caused by Chlamydia trachomatis in infant baboons: histopathologic comparison with a case in a human infant. J. Infect. Dis. 139: 953 962.
62. Harrison, H. R.,, S. M. Lee,, and D. O. Lucas. 1982. Chlamydia trachomatis pneumonitis in the C57BL/KsJ mouse: pathologic and immunologic features. J. Lab. Clin. Med. 100: 953 962.
63. Hawkins, R. A.,, K. A. Kelly,, and R. G. Rank,. 1998a. Expression of a mucosal-associated integrin may influence the trafficking of a protective MoPn-specific CD4+ clone to the GT during genital infection, p. 395 398. In R. S. Stephens,, G. I. Byrne,, G. Christiansen,, I. N. Clarke,, J. T. Grayston,, R. G. Rank,, G. L. Ridgway,, P. Saikku,, J. Schachter,, and W. E. Stamm (ed.), Chlamydial Infections. Proceedings of the Ninth International Symposium on Human Chlamydial Infection. International Chlamydia Symposium, San Francisco, Calif..
64. Hawkins, R. A.,, K. A. Kelly,, and R. G. Rank. 1998b. Unpublished work.
65. Herring, A. J.,, G. E. Jones,, S. M. Dunbar,, P. F. Nettleton,, T. A. Fitzgerald,, I. E. Anderson,, S. N. Chapman,, T. Wilson,, and T. M. A. Wilson,. 1998. Recombinant vaccines against Chlamydia psittaci—an overview of results using bacterial expression and a new approach using a plant virus overcoat system, p. 434 437. In R. S. Stephens,, G. I. Byrne,, G. Christiansen,, I. N. Clarke,, J. T. Grayston,, R. G. Rank,, G. L. Ridgway,, P. Saikku,, J. Schachter,, and W. E. Stamm (ed.), Chlamydial Infections. Proceedings of the Ninth International Symposium on Human Chlamydial Infection. International Chlamydia Symposium, San Francisco, Calif..
66. Holland, M. J.,, R. L. Bailey,, L. J. Hayes,, H. C. Whittle,, and D. C. W. Mabey. 1993. Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens. J. Infect. Dis. 168: 1528 1531.
67. Holtmann, H.,, Y. Shemer-Avni,, K. Wessel,, I. Sarov,, and D. Wallach. 1990. Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis. Infect. Immun. 58: 3168 3172.
68. Howard, L. V. 1975. Neutralization of Chlamydia trachomatis in cell culture. Infect. Immun. 11: 698 703.
69. Howard, L. V.,, M. P. O'Leary,, and R. L. Nichols. 1976. Animal model studies of genital chlamydial infections. Immunity to re-infection with guinea-pig inclusion conjunctivitis agent in the urethra and eye of male guinea-pigs. Br. J. Verier. Dis. 52: 261 265.
70. Igietseme, J. U. 1996. The molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide. Immunology 87: 1 8.
71. Igietseme, J. U.,, D. M. Magee,, D. M. Williams,, and R. G. Rank. 1994. Role for CD8 + T cells in antichlamydial immunity defined by chlamydia-specific T-lymphocyte clones. Infect. Immun. 62: 5195 5197.
72. Igietseme, J. U.,, L. L. Perry,, G. A. Ananaba,, I. M. Uriri,, O. O. Ojior,, S. N. Kumar,, and H. D. Caldwell. 1998a. Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect. Immun. 66: 1282 1286.
73. Igietseme, J. U.,, K. H. Ramsey,, D. M. Magee,, D. M. Williams,, T. J. Kincy,, and R. G. Rank. 1993. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific T H1 lymphocyte clone. Regional Immunol. 5: 317 324.
74. Igietseme, J. U.,, and R. G. Rank. 1991. Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract. Infect. Immun. 59: 1346 1351.
75. Igietseme, J. U.,, I. M. Uriri,, S. N. Kumar,, G. A. Ananaba,, O. O. Ojior,, I. A. Momodu,, D. H. Candal,, and C. M. Black. 1998b. Route of infection that induces a high intensity of gamma inter-feron-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infect. Immun. 66: 4030 4035.
76. Ingalls, R. R.,, P. A. Rice,, N. Qureshi,, K. Takayama,, J. S. Lin,, and D. T. Golenbock. 1995. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect. Immun. 63: 3125 3130.
77. Ito, J. L.,, H. R. Harrison,, R. E. Alexander,, and L. J. Billings. 1984. Establishment of genital tract infection in the CF-1 mouse by intravaginal inoculation of a human oculogenital isolate of Chlamydia trachomatis. J. Infect. Dis. 150: 577 582.
78. Ito, J. I., Jr.,, J. M. Lyons,, and L. P. Airo-Brown. 1990. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection. Infect. Immun. 58: 2021 2023.
79. Johansson, M.,, K. Schön,, M. Ward,, and N. Lycke. 1997. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect. Immun. 65: 1032 1044.
80. Johnson, A. P.,, C. M. Hetherington,, M. F. Osborn,, B. J. Thomas,, and D. Taylor-Robinson. 1980. Experimental infection of the marmoset genital tract with Chlamydia trachomatis. Br. J. Exp. Pathol. 61: 291 295.
81. Johnson, A. P.,, M. F. Osborn,, B. J. Thomas,, C. M. Hetherington,, and D. Taylor-Robinson. 1981. Immunity to reinfection of the genital tract of marmosets with Chlamydia trachomatis. Br. J. Exp. Pathol. 62: 606 613.
82. Jones, G. E.,, K. A. Jones,, J. Machell,, J. Brebner,, I. E. Anderson,, and S. How. 1995. Efficacy trials with tissue-culture grown, inactivated vaccines against chlamydial abortion in sheep. Vaccine 13: 715 723.
83. Kaltenboek, B.,, J. Huang,, M. D. Wang,, S. D. Lenz,, and D. Gao,. 1998. Genetically determined vigorous innate immunity is associated with protection against primary chlamydial lung infection in mice, but with profound disease exacerbation in reinfection, p. 403 406. In R. S. Stephens,, G. I. Byrne,, G. Christiansen,, I. N. Clarke,, J. T. Grayston,, R. G. Rank,, G. L. Ridgway,, P. Saikku,, J. Schachter,, and W. E. Stamm (ed.), Chlamydial infections. Proceedings of the Ninth International Symposium on Human Chlamydial Infection. International Chlamydia Symposium, San Francisco, Calif..
84. Katz, B. P.,, B. E. Batteiger,, and R. B. Jones. 1987. Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis. Sex. Transm. Dis. 14: 160 164.
85. Kaukoranta-Tolvanen, S.-S. E.,, A. L. Laurila,, P. Saikku,, M. Leinonen,, and K. Laitinen. 1995. Experimental Chlamydia pneumoniae infection in mice: effect of reinfection and passive immunization. Microb. Pathog. 18: 279 288.
86. Kaukoranta-Tolvanen, S.-S. E.,, A. L. Laurila,, P. Saikku,, M. Leinonen,, L. Liesirova,, and K. Laitinen. 1993. Experimental infection of Chlamydia pneumoniae in mice. Microb. Pathog. 15: 293 302.
87. Kaukoranta-Tolvanen, S.-S. E.,, T. Ronni,, M. Leinonen,, P. Saikku,, and K. Laitinen. 1996. Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb. Pathog. 21: 407 411.
88. Kaukoranta-Tolvanen, S.-S. E.,, A. M. Teppo,, K. Laitinen,, P. Saikku,, K. Linnavuori,, and M. Leinonen. 1996b. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb. Pathog. 21: 215 221.
89. Kelly, K. A.,, and R. G. Rank. 1997. Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect. Immun. 65: 5198 5208.
90. Kelly, K. A.,, E. A. Robinson,, and R. G. Rank. 1996. Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection. Infect. Immun. 64: 4976 4983.
91. Knight, S. C.,, S. Iqball,, S. Woods,, A. Stagg,, M. E. Ward,, and M. Tuffrey. 1995. A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo. Immunology 85: 8 15.
92. Koehler, J. E.,, S. Birkelund,, and R. S. Stephens. 1992. Overexpression and surface localization of the Chlamydia trachomatis major outer membrane protein in Escherichia coli. Mol. Microbiol. 6: 1087 1094.
93. Kuo, C.,, and W. J. Chen. 1980. A mouse model of Chlamydia trachomatis pneumonitis. J. Infect. Dis. 141: 198 202.
94. Lampe, M. F.,, K. G. Wong,, L. M. Kuehl,, and W. E. Stamm. 1997. Chlamydia trachomatis major outer membrane protein variants escape neutralization by both monoclonal antibodies and human immune sera. Infect. Immun. 65: 317 319.
95. Landers, D. V.,, K. Erlich,, M. Sung,, and J. Schachter. 1991. Role of L3T4-bearing T-cell populations in experimental murine chlamydial salpingitis. Infect. Immun. 59: 3774 3777.
96. Lichtenwalner, A. B.,, D. L. Patton,, Y. T. Cosgrove-Sweeney,, L. K. Gaur,, and W. E. Stamm. 1997. Evidence of genetic susceptibility to Chlamydia trachomatis-'mduced pelvic inflammatory disease in the pig-tailed macaque. Infect. Immun. 65: 2250 2253.
97. Lucero, M. E.,, and C.-C. Kuo. 1985. Neutralization of Chlamydia trachomatis cell culture infection by serovar-specific monoclonal antibodies. Infect. Immun. 50: 595 597.
98. MacDonald, A. B.,, D. McComb,, and L. Howard. 1984. Immune response of owl monkeys to topical vaccination with irradiated Chlamydia trachomatis. J. Infect. Dis. 149: 439 442.
99. Mackaness, G. B. 1971. Resistance to intracellular infection. J. Infect. Dis. 123: 439 445.
100. Maclean, I. W.,, R. W. Peeling,, and R. C. Brunham. 1988. Characterization of Chlamydia trachomatis antigens with monoclonal and polyclonal antibodies. Can. J. Microbiol. 34: 141 147.
101. Magee, D. M.,, J. U. Igietseme,, J. G. Smith,, C. A. Bleicker,, B. G. Grubbs,, J. Schachter,, R. G. Rank,, and D. M. Williams. 1993. Chlamydia trachomatis pneumonia in the severe combined immunodeficiency (SOD) mouse. Regional Immunol. 5: 305 311.
102. Magee, D. M.,, D. M. Williams,, J. G. Smith,, C. A. Bleicker,, B. G. Grubbs,, J. Schachter,, and R. G. Rank. 1995. Role of CD8 T cells in primary Chlamydia infection. Infect. Immun. 63: 516 521.
103. Malaty, R.,, C. R. Dawson,, I. Wong,, C. Lyon,, and J. Schachter. 1981. Serum and tear antibodies to Chlamydia after reinfection with guinea pig inclusion conjunctivitis agent. Investig. Ophthalmol. Vis. Sci. 21: 833 841.
104. Manning, D. S.,, and S. J. Stewart. 1993. Expression of the major outer membrane protein of Chlamydia trachomatis in Escherichia coli. Infect. Immun. 61: 4093 4098.
105. Masson, P. L.,, J. F. Heremans,, and J. Ferin. 1969. Clinical importance of the biochemical changes in the female genital tract. I. Studies on the proteins of cervical mucus. Int. J. Fértil. 14: 1 7.
106. Mayer, J.,, M. L. Woods,, Z. Vavrin,, and J. B. Hibbs. 1993. Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells. Infect. Immun. 61: 491 497.
107. McDermott, M. R.,, and J. Bienenstock. 1979. Evidence for a common mucosal immunologic system. I. Migration of T immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 122: 1892 1898.
108. McEwen, A. D.,, J. T. Stamp,, and A. I. Littlejohn. 1951. Enzootic abortion of ewes. II. Immunisation and infection experiments. Vet. Ree. 63: 197 201.
109. Megran, D. W.,, H. G. Stiver,, and W. R. Bowie. 1985. Complement activation and stimulation of chemotaxis by Chlamydia trachomatis. Infect. Immun. 49: 670 673.
110. Modabber, F.,, S. E. Bear,, and J. Cerny. 1976. The effect of cyclophosphamide on the recovery from a local chlamydial infection—guinea pig inclusion conjunctivitis. Immunology 30: 929 933.
111. Monnickendam, M. A.,, S. Darougar,, J. D. Treharne,, and A. M. Tilbury. 1980a. Guinea pig inclusion conjunctivitis as a model for the study of trachoma: clinical, microbiological, serological, and cyto-logical studies of primary infection. Br. J. Ophthalmol. 64: 279 283.
112. Monnickendam, M. A.,, S. Darougar,, J. D. Treharne,, and A. M. Tilbury. 1980b. Development of chronic conjunctivitis with scarring and pannus, resembling trachoma, in guinea pigs. Br. J. Ophthalmol. 64: 284 290.
113. Montgomery, P. C.,, K. M. Connelly,, J. Cohn,, and C. A. Skandera. 1978. Remote-site stimulation of secretory IgA antibodies following bronchial and gastric stimulation. Adv. Exp. Med. Biol. 107: 113 122.
114. Morrison, R. P.,, R. J. Belland,, K. Lyng,, and H. D. Caldwell. 1989. Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J. Exp. Med. 170: 1271 1283.
115. Morrison, R. P.,, K. Feilzer,, and D. B. Turnas. 1995. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect. Immun. 63: 4661 4668.
116. Mount, D. T.,, P. E. Bigazzi,, and A. L. Barron. 1972. Infection of genital tract and transmission of ocular infection to newborns by the agent of guinea pig inclusion conjunctivitis. Infect. Immun. 5: 921 926.
117. Mount, D. T.,, P. E. Bigazzi,, and A. L. Barron. 1973. Experimental genital infection of male guinea pigs with the agent of guinea pig inclusion conjunctivitis and transmission to females. Infect. Immun. 8: 925 930.
118. Mull, J. D.,, and S. E. Thompson III. 1973. The effect of antilymphocyte globulin on guinea pig resistance to ocular chlamydial infection, abstr. V 33, p. 200. In Abstracts of Annual Meeting of the American Society for Microbiology 1973. American Society for Microbiology, Washington, D.C..
119. Murdin, A. D.,, H. Su,, M. H. Klein,, and H. D. Caldwell. 1995. Poliovirus hybrids expressing neutralization epitopes from variable domains I and IV of the major outer membrane protein of Chlamydia trachomatis elicit broadly cross-reactive C. trachomatis-neutralizing antibodies. Infect. Immun. 63: 1116 1121.
120. Murdin, A. D.,, H. Su,, D. S. Manning,, M. H. Klein,, M. J. Parnell,, and H. D. Caldwell. 1993. A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic. Infect. Immun. 61: 4406 4414.
121. Murray, E. S. 1964. Guinea pig inclusion conjunctivitis. I. Isolation and identification as a member of the psittacosis-lymphogranuloma-trachoma group. J. Infect. Dis. 114: 1 12.
122. Murray, E. S.,, and F. T. Radcliffe. 1967. Immunologic studies in guinea pigs with guinea pig inclusion conjunctivitis (Gp-ic) Bedsonia. Am. J. Ophthalmol. 63: 1263 1269.
123. Newhall, W. J.,, B. Batteiger,, and R. B. Jones. 1982. Analysis of the human serological response to proteins of Chlamydia trachomatis. Infect. Immun. 38: 1181 1189.
124. Nichols, R. L.,, E. S. Murray,, and P. E. Nisson. 1978. Use of enteric vaccines in protection against chlamydial infections of the genital tract and the eye of guinea pigs. J. Infect. Dis. 138: 742 746.
125. Nichols, R. L.,, R. E. Oertley,, C. E. O. Fraser,, A. B. MacDonald,, and D. E. McComb. 1973. Immunity to chlamydial infections of the eye. VI. Homologous neutralization of trachoma infectivity for the owl monkey conjunctivae by eye secretions from humans with trachoma. J. Infect. Dis. 127: 429 432.
126. Nigg, C. 1942. An unidentified virus which produces pneumonia and systemic infection in mice. Science 95: 49 50.
127. Orenstein, N. S.,, J. D. Mull,, and S. E. I. Thompson. 1973. Immunity to chlamydial infections of the eye. V. Passive transfer of antitrachoma antibodies to owl monkeys. Infect. Immun. 7: 600 603.
128. Ortiz, L.,, K. P. Demick,, J. W. Petersen,, M. Polka,, R. A. Rudersdorf,, B. Van der Pol,, R. Jones,, M. Angevine,, and R. DeMars. 1996. Chlamydia trachomatis major outer membrane protein (MOMP) epitopes that activate HLA class II-restricted T cells from infected humans. J. Immunol. 157: 4554 4567.
129. Pal, S.,, K. M. Barnhart,, A. M. Abai,, E. M. Peterson,, and L. M. de la Maza,. 1998. Immunization of mice with expression plasmids containing DNA sequences corresponding to the C. trachomatis MOMP failed to protect against a genital challenge, p. 438 439. In R. S. Stephens,, G. I. Byrne,, G. Christiansen,, I. N. Clarke,, J. T. Grayston,, R. G. Rank,, G. L. Ridgway,, P. Saikku,, J. Schachter,, and W. E. Stamm (ed.), Chlamydial Infections. Proceedings of the Ninth International Symposium on Human Chlamydial Infection. International Chlamydia Symposium, San Francisco, Calif..
130. Pal, S.,, T. Fielder,, E. M. Peterson,, and L. de la Maza. 1993. Analysis of the immune response in mice following intrauterine infection with the Chlamydia trachomatis mouse pneumonitis biovar. Infect. Immun. 61: 772 776.
131. Pal, S.,, T. J. Fielder,, E. M. Peterson,, and L. M. de la Maza. 1994. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun. 62: 3354 3362.
132. Pal, S.,, E. M. Peterson,, and L. M. de la Maza. 1996. Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge. Infect. Immun. 64: 5341 5348.
133. Pal, S.,, I. Theodor,, E. M. Peterson,, and L. M. de la Maza. 1997a. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge. Vaccine 15: 575 582.
134. Pal, S.,, I. Theodor,, E. M. Peterson,, and L. M. de la Maza. 1997b. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge. Infect. Immun. 65: 3361 3369.
135. Pasley, J. N.,, R. G. Rank,, A. J. Hough,, C. Cohen,, and A. L. Barron. 1985. Absence of progesterone effects on chlamydial genital infection in female guinea pigs. Sex. Transm. Dis. 12: 155 158.
136. Patterson, T. L.,, and R. G. Rank. 1996. Immunity to reinfection and immunization of male guinea pigs against urethral infection with the agent of guinea pig inclusion conjunctivitis. Sex. Transm. Dis. 23: 145 150.
137. Patton, D. L.,, S. A. Halbert,, K. C. Kuo,, S. P. Wang,, and K. K. Holmes. 1983. Host response to primary Chlamydia trachomatis infection of the fallopian tube in pig-tailed monkeys. Fértil. Steril. 40: 829 840.
138. Patton, D. L.,, C.-C. Kuo,, S.-P. Wang,, R. M. Brenner,, M. D. Sternfeld,, S. A. Morse,, and R. C. Barnes. 1987a. Chlamydial infection of subcutaneous fimbrial transplants in cynomolgus and rhesus monkeys. J. Infect. Dis. 155: 229 235.
139. Patton, D. L.,, C.-C. Kuo,, S.-P. Wang,, and S. A. Halbert. 1987b. Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infection in pig-tailed macaques. J. Infect. Dis. 155: 1292 1299.
140. Pavia, C. S.,, and J. Schachter. 1983. Failure to detect cell-mediated cytotoxicity against Chlamydia trachomatis infected cells. Infect. Immun. 39: 1271 1274.
141. Pearce, J. H.,, I. Allan,, and S. Ainsworth. 1981. Interaction of chlamydiae with host cells and mucous surfaces. Ciba Found. Symp. 80: 234 251.
142. Peeling, R.,, I. W. Maclean,, and R. C. Brunham. 1984. In vitro neutralization of Chlamydia trachomatis with monoclonal antibody to an epitope on the major outer membrane protein. Infect. Immun. 46: 484 488.
143. Perry, L. L.,, K. Feilzer,, and H. D. Caldwell. 1997. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J. Immunol. 158: 3344 3352.
144. Peterson, E. M.,, L. M. de la Maza,, L. Brade,, and H. Brade. 1998. Characterization of a neutralizing monoclonal antibody directed at the lipopolysaccharide of Chlamydia pneumoniae. Infect. Immun. 66: 3848 3855.
145. Puolakkainen, M.,, J. Parker,, C. C. Kuo,, J. T. Grayston,, and L. A. Campbell. 1995. Further characterization of Chlamydia pneumoniae specific monoclonal antibodies. Microbiol. Immunol. 39: 551 554.
146. Qu, Z.,, X. Cheng,, L. M. de la Maza,, and E. M. Peterson. 1993. Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars. Infect. Immun. 61: 1365 1370.
147. Qvigstad, E.,, and H. Hirschberg. 1984. Lack of cell-mediated cytotoxicity towards Chlamydia trachomatis infected target cells in humans. Acta Pathol. Microbiol. Immunol. 92: 153 159.
148. Ramsey, K. H.,, G. S. Miranpuri,, C. E. Poulsen,, N. B. Marthakis,, L. M. Braune,, and G. I. Byrne. 1998. Inducible nitric oxide synthase does not affect resolution of murine chlamydial genital tract infections or eradication of chlamydiae in primary murine cell culture. Infect. Immun. 66: 835 838.
149. Ramsey, K. H.,, W. J. Newhall,, and R. G. Rank. 1989. Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis. Infect. Immun. 57: 2441 2446.
150. Ramsey, K. H.,, and R. G. Rank. 1991. Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect. Immun. 59: 925 931.
151. Ramsey, K. H.,, L. S. F. Soderberg,, and R. G. Rank. 1988. Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection, infect. Immun. 56: 1320 1325.
152. Rank, R. G. 1998. Unpublished work.
153. Rank, R. G.,, and A. L. Barron,. 1982. Prolonged genital infection by GPIC agent associated with immunosuppression following treatment with estradiol, p. 391 394. In P.-A. Mardh,, K. K. Holmes,, J. D. Oriel,, P. Piot,, and J. Schachter (ed.), Chlamydial Infections. Elsevier Biomedical Press, New York, N.Y..
154. Rank, R. G.,, and A. L. Barron. 1983a. Humoral immune response in acquired immunity to chlamydial genital infection of female guinea pigs. Infect. Immun. 39: 463 465.
155. Rank, R. G.,, and A. L. Barron. 1983b. Effect of antithymocyte serum on the course of chlamydial genital infection in female guinea pigs. Infect, immun. 41: 876 879.
156. Rank, R. G.,, and A. L. Barron. 1987. Specific effect of estradiol on the genital mucosal antibody response in chlamydial ocular and genital infections. Infect. Immun. 55: 2317 2319.
157. Rank, R. G.,, and B. E. Batteiger. 1989. Protective role of serum antibody in immunity to chlamydial genital infection. Infect. Immun. 57: 299 301.
158. Rank, R. G.,, B. E. Batteiger,, and L. S. F. Soderberg. 1988. Susceptibility to reinfection after a primary chlamydial genital infection. Infect. Immun. 56: 2243 2249.
159. Rank, R. G.,, B. E. Batteiger, and L, S. F. Soderberg. 1990. Immunization against chlamydial genital infection in guinea pigs with UV-inactivated and viable chlamydiae administered by different routes. Infect. Immun. 58: 2599 2605.
160. Rank, R. G.,, K. H. Ramsey,, E. A. Pack,, and D. M. Williams. 1992. Effect of gamma interferon on resolution of murine chlamydial genital infection. Infect. Immun. 60: 4427 4429.
161. Rank, R. G.,, and M. M. Sanders. 1992. Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection. Am. J. Pathol. 140: 927 936.
162. Rank, R. G.,, and M. M. Sanders. 1998. Unpublished work.
163. Rank, R. G.,, M. M. Sanders,, and D. L. Patton. 1995. Increased incidence of oviduct pathology in the guinea pig after repeat vaginal inoculation with the chlamydial agent of guinea pig inclusion conjunctivitis. Sex. Transm. Dis. 22: 48 54.
164. Rank, R. G.,, L. S. F. Soderberg,, and A. L. Barron. 1985a. Chronic chlamydial genital infection in congenitally athymic nude mice. Infect. Immun. 48: 847 849.
165. Rank, R. G.,, A. J. Hough, Jr.,, R. F. Jacobs,, C. Cohen,, and A. L. Barron. 1985b. Chlamydial pneumonitis induced in newborn guinea pigs. Infect. Immun. 48: 153 158.
166. Rank, R. G.,, L. S. F. Soderberg,, M. M. Sanders,, and B. E. Batteiger. 1989. Role of cell-mediated immunity in the resolution of secondary chlamydial genital infection in guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect. Immun. 57: 706 710.
167. Rank, R. G.,, H. J. White,, and A. L. Barron. 1979. Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect, immun. 26: 573 579.
168. Rank, R. G.,, H. J. White,, B. L. Soloff,, and A. L, Barron. 1981. Cystitis associated with chlamydial infection of the genital tract in male guinea pigs. Sex. Transm. Dis. 8: 203 210.
169. Rasmussen, S. J.,, L. Eckmann,, A. J. Quayle,, L. Shen,, Y. X. Zhang,, D. J. Anderson,, J. Fierer,, R. S. Stephens,, and M. F. Kagnoff. 1997. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J. Clin. Invest. 99: 77 87.
170. Rasmussen, S. J.,, C. K. Sen,, and R. S. Stephens,. 1998. Temporal expression of interleukin-8 in Chlamydia-'mfected epithelial cells, p. 411 414. In R. S. Stephens,, G. I. Byrne,, G. Christiansen,, I. N. Clarke,, J. T. Grayston,, R. G. Rank,, G. L. Ridgway,, P. Saikku,, J. Schachter,, and W. E. Stamm (ed.), Chlamydial Infections. Proceedings of the Ninth International Symposium on Human Chlamydial Infection. International Chlamydia Symposium, San Francisco, Calif..
171. Reeve, P.,, and D. M. Graham. 1962. A neutralization test for trachoma and inclusion blennorrhea viruses grown in HeLa cells. J. Gen. Microbiol. 27: 177 180.
172. Register, K. B.,, C. H. Davis,, P. B. Wyrick,, W. M. Shafer,, and J. K. Spitznagel. 1987. Nonoxidative antimicrobial effects of human polymorphonuclear leukocyte granule proteins on Chlamydia spp. In vitro. Infect. Immun. 55: 2420 2427.
173. Register, K. B.,, P. A. Morgan,, and P. B. Wyrick. 1986. Interaction between Chlamydia spp. and human polymorphonuclear leukocytes in vitro. Infect. Immun. 52: 664 670.
174. Rodolakis, A. 1983. In vitro and in vivo properties of chemically induced temperature sensitive mutants of Chlamydia psittaci var. ovis: screening in a murine model. Infect. Immun. 42: 525 530.
175. Rodolakis, A.,, and F. Bernard. 1984. Vaccination with temperature sensitive mutant of Chlamydia psittaci against enzootic abortion of ewes. Vet. Ree. 114: 193 194.
176. Rothermel, C. D.,, B. Y. Rubin,, and H. W. Murray. 1983a. Gamma interferon is the factor in lym-phokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication. J. Immunol. 131: 2542 2544.
177. Rothermel, C. D.,, G. I. Byrne,, and E. A. Havell. 1983b. Effect of interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells). Infect. Immun. 39: 362 370.
178. Rothermel, C. D.,, J. Schachter,, P. Lavrich,, E. C. Lipsitz,, and T. Francus. 1989. Chlamydia tra-chomatis-induced production of interleukin-1 by human monocytes. Infect. Immun. 57: 2705 2711.
179. Sacks, D. L.,, W. J. Todd,, and A. B. MacDonald. 1978. Cell-mediated immune responses in owl monkeys (Aotus trivirgatus) with trachoma to soluble antigens of Chlamydia trachomatis. Clin. Exp. Immunol. 33: 57 64.
180. Schachter, J.,, and C. R. Dawson. 1978. Human Chlamydial Infections. PSG Publishing Company, Littleton, Mass..
181. Shemer-Avni, Y.,, D. Wallach,, and I. Saro v. 1988. Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor. Infect. Immun. 56: 2503 2506.
182. Shewen, P. E.,, R. C. Povey,, and M. R. Wilson. 1980. A comparison of the efficacy of a live and four inactivated vaccine preparations for the protection of cats against experimental challenge with Chlamydia psittaci. Can. J. Comp. Med. 44: 244 251.
183. Stagg, A. J.,, M. Tuffrey,, C. Woods,, E. Wunderink,, and S. C. Knight 1998. Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect. Immun. 66: 3535 3544.
184. Starnbach, M. N.,, M. J. Bevan,, and M. F. Lampe. 1994. Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J. Immunol. 153: 5183 5189.
185. Starnbach, M. N.,, M. J. Bevan,, and M. F. Lampe. 1995. Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars. Infect. Immun. 63: 3527 3530.
186. Stephens, R. S.,, S. Kalman,, S. J. Lammel,, J. Fan,, R. Marathe,, L. Aravind,, W. P. Mitchell,, L. Olinger,, R. L. Tatusov,, Q. Zhao,, E. V. Koonin,, and R. W. Davis. 1998. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282: 754 759.
187. Stephens, R. S.,, E. A. Wagar,, and G. K. Schoolnik. 1988. High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J. Exp. Med. 167: 817 831.
188. Stuart, E. S.,, S. M. Tirrell,, and A. B. MacDonald. 1987. Characterization of an antigen secreted by Chlamydia-infected cell culture. Immunology 61: 527 533.
189. Su, H.,, and H. D. Caldwell. 1992. Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein. J. Exp. Med. 175: 227 235.
190. Su, H.,, and H. D. Caldwell. 1993. Immunogenicity of a synthetic oligopeptide corresponding to anti-genically common T-helper and B-cell neutralizing epitopes of the major outer membrane protein of Chlamydia trachomatis. Vaccine 11: 1159 1166.
191. Su, H.,, and H. D. Caldwell. 1995. CD4 + T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect. Immun. 63: 3302 3308.
192. Su, H.,, K. Feilzer,, H. D. Caldwell,, and R. P. Morrison. 1997. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 65: 1993 1999.
193. Su, H.,, R. Messer,, W. Whitmore,, E. Fischer,, J. C.. Portis, and H. D. Caldwell. 1998. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae. J. Exp. Med. 188: 809 818.
194. Su, H.,, R. P. Morrison,, N. G. Watkins,, and H. D. Caldwell. 1990. Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. J. Exp. Med. 172: 203 212.
195. Su, H.,, M. Parnell,, and H. D. Caldwell. 1995. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection. Vaccine 13: 1023 1032.
196. Su, H.,, G. J. Spangrude,, and H. D. Caldwell. 1991. Expression of FcyRIII on HeLa 229 cells: possible effect on in vitro neutralization of Chlamydia trachomatis. Infect. Immun. 59: 3811 3814.
197. Tan, T.-W.,, A. J. Herring,, I. E. Anderson,, and G. E. Jones. 1990. Protection of sheep against Chlamydia psittaci infection with a subcellular vaccine containing the major outer membrane protein. Infect. Immun. 58: 3101 3108.
198. Taylor, H. R.,, S. L. Johnson,, R. A. Prendergast,, J. Schachter,, C. R. Dawson,, and A. M. Silverstein. 1982. An animal model of trachoma. II. The importance of repeated reinfection. Investig. Ophthalmol. Vis. Sci. 23: 507 515.
199. Taylor, H. R.,, and R. A. Prendergast. 1987. Attempted oral immunization with chlamydial lipopoly-saccharide subunit vaccine. Investig. Ophthalmol. Vis. Sci. 28: 3061 3063.
200. Taylor, H. R.,, R. A. Prendergast,, C. R. Dawson,, J. Schachter,, and A. M. Silverstein. 1981. An animal model for cicatrizing trachoma. Investig. Ophthalmol. Vis. Sci. 21: 422 433.
201. Taylor, H. R.,, J. Whittum-Hudson,, J. Schachter,, H. D. Caldwell,, and R. A. Prendergast. 1988. Oral immunization with chlamydial major outer membrane protein (MOMP). Investig. Ophthalmol Vis. Sci. 29: 1847 1853.
202. Taylor, H. R.,, E. Young,, A. B. MacDonald,, J. Schachter,, and R. A. Prendergast. 1987. Oral immunization against chlamydial eye infection. Investig. Ophthalmol. Vis. Sci. 28: 249 258.
203. Tipple, M. A.,, M. O. Beem,, and E. M. Saxon. 1979. Clinical characteristics of the afebrile pneumonia associated with Chlamydia trachomatis infection in infants less than 6 months of age. Pediatrics 63: 192 197.
204. Tseng, C.-T. K.,, and R. G. Rank. 1998. Role of NK cells in early host response to chlamydial genital infection. Infect. Immun. 66: 5867 5875.
205. Tuffrey, M.,, F. Alexander,, and D. Taylor-Robinson. 1990. Severity of salpingitis in mice after primary and repeated inoculation with a human strain of Chlamydia trachomatis. J. Exp. Pathol. 71: 403 410.
206. Tuffrey, M.,, F. Alexander,, C. Woods,, and D. Taylor-Robinson. 1992a. Genetic susceptibility to chlamydial salpingitis and subsequent infertility in mice. J. Reprod. Fértil. 95: 31 38.
207. Tuffrey, M.,, F. Alexander,, W. Conlan,, C. Woods,, and M. Ward. 1992b. Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar LÍ major outer-membrane protein. J. Gen. Microbiol. 138: 1707 1715.
208. Tuffrey, M.,, P. Falder,, and D. Taylor-Robinson. 1982. Genital tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis. Br. J. Exp. Pathol. 63: 539 546.
209. Tuffrey, M.,,, and D. Taylor-Robinson. 1981. Progesterone as a key factor in the development of a mouse model for genital-tract infection with Chlamydia trachomatis. FEMS Microbiol. Lett. 12: 111 115.
210. Van Voorhis, W. C.,, L. K. Barrett,, Y. T. C. Sweeney,, C.-C. Kuo,, and D. L. Patton. 1997. Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Thl-like cytokine response associated with fibrosis and scarring. Infect. Immun. 65: 2175 2182.
211. Van Voorhis, W. C.,, L. K. Barrett,, Y. T. C. Sweeney,, C. C. Kuo,, and D. L. Patton. 1996. Analysis of lymphocyte phenotype and cytokine activity in the inflammatory infiltrates of the upper genital tract of female macaques infected with Chlamydia trachomatis. J. Infect. Dis. 174: 647 650.
212. Wang, S.-P.,, and J. T. Grayston. 1967. Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys. Am. J. Ophthalmol. 63: 1133 1145.
213. Wang, S. P.,, J. T. Grayston,, and E. R. Alexander. 1967. Trachoma vaccine studies in monkeys. Am. J. Ophthalmol. 63: 1615 1630.
214. Watson, R. R.,, J. D. Mull,, A. B. MacDonald,, S. E. Thompson III,, and S. E. Bear. 1973a. Immunity to chlamydial infections of the eye. II. Studies of passively transferred serum antibody in resistance to infection with guinea pig inclusion conjunctivitis. Infect. Immun. 7: 597 599.
215. Watson, R. R.,, A. B. MacDonald,, E. S. Murray,, and F. Z. Modabber. 1973b. Immunity to chlamydial infections of the eye. III. Presence and duration of delayed hypersensitivity to guinea pig inclusion conjunctivitis. J. Immunol. 111: 618 623.
216. Watson, R. R.,, E. S. Murray,, and S. E. Thompson III. 1973c. Studies of transplacentally and passively transferred antibody in resistance to eye infection by a chlamydial agent, guinea pig inclusion conjunctivitis. Fed. Proc, abstr. 1029.
217. Westbay, T. D.,, C. C. Dascher,, R.-C. Hsia,, P. M. Bavoil,, and M. Zauderer. 1994. Dissociation of immune determinants of outer membrane proteins of Chlamydia psittaci strain guinea pig inclusion conjunctivitis. Infect. Immun. 62: 5614 5623.
218. White, D. W.,, and J. T. Harty. 1998. Perforin-deficient CD8 + T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD95 and DFN-gamma but requires TNF-α. J. Immunol. 160: 898 905.
219. White, H. J.,, R. G. Rank,, B. L. Soloff,, and A. L. Barron. 1979. Experimental chlamydial salpingitis in immunosuppressed guinea pigs infected in the genital tract with the agent of guinea pig inclusion conjunctivitis. Infect. Immun. 26: 728 735.
220. Whittum-Hudson, J. A.,, L. L. An,, W. M. Saltzman,, R. A. Prendergast,, and A. B. MacDonald. 1996. Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection. Nat. Med. 2: 1116 1121.
221. Whittum-Hudson, J. J.,, T. P. O'Brien,, and R. A. Prendergast. 1995. Murine model of ocular infection by a human biovar of Chlamydia trachomatis. Investig. Ophthalmol. Vis. Sci. 36: 1976 1987.
222. Whittum-Hudson, J. J.,, H. R. Taylor,, M. Farazdaghi,, and R. A. Prendergast. 1986. Immunohisto-chemical study of the local inflammatory response to chlamydial ocular infection. Investig. Ophthalmol. Vis. Sci. 27: 64 69.
223. Williams, D. M.,, G. I. Byrne,, B. Grubbs,, T. J. Marshal,, and J. Schachter. 1988. Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice. Infect. Immun. 56: 3004 3006.
224. Williams, D. M.,, B. Grubbs,, T. Darville,, K. Kelly,, and R. Rank,. 1998. A role for interleukin 6 in host defense against Chlamydia trachomatis, p. 387 390. In R. S. Stephens,, G. I. Byrne,, G. Christiansen,, I. N. Clarke,, J. T. Grayston,, R. G. Rank,, G. L. Ridgway,, P. Saikku,, J. Schachter,, and W. E. Stamm (ed.), Chlamydial Infections. Proceedings of the Ninth International Symposium on Human Chlamydial Infection. I nternational Chlamydia Symposium, San Francisco, Calif..
225. Williams, D. M.,, B. Grubbs,, K. A. Kelly,, and R. G. Rank. 1997. Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis. Infect. Immun. 65: 2876 2882.
226. Williams, D. M.,, B. G. Grubbs,, K. Kelly,, E. Pack,, and R. G. Rank. 1996. Role of gamma-delta T cells in murine Chlamydia trachomatis infection. Infect. Immun. 64: 3916 3919.
227. Williams, D. M.,, B. G. Grubbs,, J. Schachter,, and D. M. Magee. 1993. Gamma interferon levels during Chlamydia trachomatis pneumonia in mice. Infect. Immun. 61: 3556 3558.
228. Williams, D. M.,, T. Kung,, and J. Schachter,. 1986. Immunity to the mouse pneumonitis agent (murine Chlamydia trachomatis), p. 465 468. In D. Oriel,, G. Ridgway,, J. Schachter,, D. Taylor-Robinson,, and M. Ward (ed.), Chlamydial Infections. Cambridge University Press, Cambridge, England.
229. Williams, D. M.,, D. M. Magee,, L. E Bonewald,, J. G. Smith,, C. A. Bleicker,, G. I. Byrne,, and J. Schachter. 1990. A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect. Immun. 58: 1572 1576.
230. Williams, D. M.,, and J. Schachter. 1985. Role of cell-mediated immunity in chlamydial infection: implications for ocular immunity. Rev. Infect. Dis. 7: 754 759.
231. Williams, D. M.,, J. Schachter,, J. J. Coalson,, and B. Grubbs. 1984a. Cellular immunity to the mouse pneumonitis agent. J. Infect. Dis. 149: 630 639.
232. Williams, D. M.,, J. Schachter,, D. J. Drutz,, and C. V. Sumaya. 1981. Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse. J. Infect. Dis. 143: 238 241.
233. Williams, D. M.,, J. Schachter,, and B. Grubbs. 1987a. Role of natural killer cells in infection with the mouse pneumonitis agent (murine Chlamydia trachomatis). Infect. Immun. 55: 223 226.
234. Williams, D. M.,, B. Grubbs,, and J. Schachter. 1987b. Primary murine Chlamydia trachomatis pneumonia in B-cell-deficient mice. Infect. Immun. 55: 2387 2390.
235. Williams, D. M.,, J. Schachter,, B. Grubbs,, and C. V. Sumaya. 1982. The role of antibody in host defense against the agent of mouse pneumonitis. J. Infect. Dis. 145: 200 205.
236. Williams, D. M.,, J. Schachter,, M. H. Weiner,, and B. Grubbs. 1984b. Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis) . Infect. Immun. 45: 674 678.
237. Wills, J. M.,, T. J. Gruffydd-Jones,, S. J. Richmond,, R. M. Gaskell,, and F. J. Bourne. 1987. Effect of vaccination on feline Chlamydia psittaci infection. Infect. Immun. 55: 2653 2657.
238. Woolridge, R. L.,, J. T. Grayston,, I. H. Chang,, C. Y. Yang,, and K. H. Cheng. 1967. Long-term follow-up of the initial (1959-1960) trachoma vaccine field trial on Taiwan. Am. J. Ophthalmol. 63: 1650 1653.
239. Wyrick, P. B.,, and E. A. Brownridge. 1978. Growth of Chlamydia psittaci in macrophages. Infect. Immun. 19: 1054 1060.
240. Wyrick, P. B.,, E. A. Brownridge,, and A. E. Ivins. 1978. Interaction of Chlamydia psittaci with mouse peritoneal macrophages. Infect. Immun. 19: 1061 1067.
241. Yang, X.,, K. T. Hayglass,, and R. C. Brunham. 1996. Genetically determined differences in IL-10 and IFN-γ responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J. Immunol. 156: 4338 4344.
242. Yang, Z.-P.,, C.-C. Kuo,, and J. T. Grayston. 1993. A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis. Infect. Immun. 61: 2037 2040.
243. Yong, E. C.,, E. Y. Chi,, W.-J. Chen,, and C.-C. Kuo. 1986. Degradation of Chlamydia trachomatis in human polymorphonuclear leukocytes: an ultrastructural study of peroxidase-positive phagolysosomes. Infect. Immun. 53: 427 431.
244. Zhang, D. J.,, X. Yang,, J. Berry,, C. X. Shen,, G. McCIarty,, and R. C. Brunham. 1997. DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J. Infect. Dis. 176: 1035 1040.
245. Zhang, Y. X.,, S. Stewart,, T. Joseph,, H. R. Taylor,, and H. D. Caldwell. 1987. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J. Immunol. 138: 575 581.
246. Zhang, Y.-X.,, S. J. Stewart,, and H. D. Caldwell. 1989. Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants. Infect. Immun. 57: 636 638.
247. Zhong, G.,, and R. C. Brunham. 1992. Antibody responses to the chlamydial heat shock proteins Hsp60 and Hsp70 are H-2 linked. Infect. Immun. 60: 3143 3149.
248. Zhong, G.,, G. P. Smith,, J. Berry,, and R. C. Brunham. 1994. Conformational mimicry of a chlamydial neutralization epitope on filamentous phage. J. Biol. Chem. 269: 24183 24188.
249. Zhong, G.,, I. Toth,, R. Reid,, and R. C. Brunham. 1993. Immunogenicity evaluation of a lipidie amino acid-based synthetic peptide vaccine for Chlamydia trachomatis. J. Immunol. 151: 3728 3736.

Tables

Generic image for table
Table 1

Summary of immunization and challenge experiments and results of challenge infections

Citation: Rank R. 1999. Models of Immunity, p 239-295. In Stephens R (ed), Chlamydia. ASM Press, Washington, DC. doi: 10.1128/9781555818203.ch9

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error